CinRx Pharma

About:

CinRx Pharma develops therapies for unmet needs, leveraging partnerships and expertise to advance new molecular entities.

Website: http://www.cinrx.com

Twitter/X: cinrx_pharma

Description:

CinRx Pharma was launched in September of 2015 to transform the development of innovative therapies addressing substantial unmet medical needs. With leading CRO Medpace as a strategic partner, CinRx leverages its cost-efficient structure while having access to global clinical development expertise and networks of advisors, critical understanding of the evolving regulatory environment, and industry-leading track records of execution across all stages of R&D. CinRx’s therapeutic pipeline focuses on innovative and disruptive new molecular entities (NMEs). CinRx pursues an expedited path of development to achieve significant value inflection points for each of its programs. Once a compound has demonstrated clinical and commercial value, CinRx will determine the optimal strategy to bring the product to patients.

Total Funding Amount:

$111M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cincinnati, Ohio, United States

Founded Date:

2015-09-01

Contact Email:

info(AT)cinrx.com

Founders:

Brian Murphy, Catherine Pearce, Jonathan Isaacsohn, Piyush Patel

Number of Employees:

11-50

Last Funding Date:

2024-05-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai